Viral Hepatitis
Copyright ©The Author(s) 2003.
World J Gastroenterol. Jul 15, 2003; 9(7): 1491-1495
Published online Jul 15, 2003. doi: 10.3748/wjg.v9.i7.1491
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Virological response. Percentages of patients with HBV DNA negativity related either to the treatment or to the follow-up times. The vertical lines were drawn at the end of each treatment (19 mo for interferon and lamivudine in combination, and 12 mo for lamivudine and interferon monotherapy).
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Biochemical response. Percentages of patients with normal ALT levels related either to the treatment or to the follow-up times. The vertical lines were drawn at the end of each treatment (19 mo for interferon and lamivudine in combination, and 12 mo for lamivudine and interferon monotherapy).
  • Citation: Jaboli MF, Fabbri C, Liva S, Azzaroli F, Nigro G, Giovanelli S, Ferrara F, Miracolo A, Marchetto S, Montagnani M, Colecchia A, Festi D, Reggiani LB, Roda E, Mazzella G. Long-term alpha interferon and lamivudine combination therapy in non-responder patients with anti-HBe-positive chronic hepatitis B: Results of an open, controlled trial. World J Gastroenterol 2003; 9(7): 1491-1495
  • URL: https://www.wjgnet.com/1007-9327/full/v9/i7/1491.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v9.i7.1491